Document:

TAURIGA
SCIENCES INC. (OTCQB: TAUG)

555
Madison Avenue, 5’h Floor

New
York, NY 10022

Attn:
Seth M. Shaw, Chief Executive Officer

AGREEMENT
FOR CONSULTANT TO THE COMPANY

With

J.
Safier Enterprises LLC

January
11, 2019

 

This
(this “Agreement”), dated as of January 11, 2019 (the “Effective Date”), by and between Tauriga Sciences
Inc., located in New York, NY 10022 (the “Company”), and J. Safier Enterprises LLC, a sole proprietorship operated
by Mr. Jamie Safier (“Mr. Safier”) with an address at 6 The Hemlocks / Roslyn, NY 11576 (the “Consultant”).

 

1.
Term.

 

(a)
This Agreement shall continue for a period of twelve (12) months from the Effective Date.

 

(b)
Notwithstanding the foregoing and provided that neither the Company nor the Consultant has terminated this Agreement pursuant
to Section 4(a) hereofh, the Company agrees to use its best efforts to cause the Consultant to be retained after 12 months if
both parties can agree upon the mutually beneficial nature of the relationship.

 

2.
Position and Responsibilities.

 

(a)
Position. Company hereby retains Consultant to assist the Company in numerous capacities relating to introductions to potential
accredited investors and institutional investors, introductions to potential customers for Tauri-Gum product line, and introductions
to potential merger and acquisition candidates to evaluate for Tauriga Sciences Inc.

 

(b)
Other Activities. Consultant may be employed by another company, may serve on other Boards of Directors or Advisory Boards, and
may engage in any other business activity (whether or not pursued for pecuniary advantage), as long as such outside activities
do not violate Consultant’s obligations under this Agreement or Consultant’s fiduciary obligations to the shareholders.
The ownership of less than a 10% interest in an entity, by itself, shall not constitute a violation of this duty. Consultant represents
that, to the best of his knowledge, Consultant has no outstanding agreement or obligation that is in conflict with any of the
provisions of this Agreement, and Consultant agrees to use his best efforts to avoid or minimize any such conflict and agrees
not to enter into any agreement or obligation that could create such a conflict, without the approval of a majority of the Board
of Directors Members. If, at any time, Consultant is required to make any disclosure or take any action that may conflict with
any of the provisions of this Agreement, Consultant will promptly notify the Board of such obligation, prior to making such disclosure
or taking such action.

 

    	 	 	 

     

    

 

(c)
No Conflict. Except as set forth in Section 2(b), Consultant will not engage in any activity that creates an actual conflict of
interest with Company, regardless of whether such activity is prohibited by Company’s conflict of interest guidelines or
this Agreement, and Consultant agrees to notify the Board of Directors before engaging in any activity that creates a potential
conflict of interest with Company. Specifically and except as set forth in Section 2(b) of this Agreement, Consultant shall not
engage in any activity that is in direct competition with the Company or serve in any capacity (including, but not limited to,
as a consultant, advisor or Board Member) in any company or entity that competes directly with the Company, as reasonably determined
by a majority of Company’s disinterested board members, without the approval of the Board of Directors Members.

 

3.
Compensation and Benefits.

 

(a)
CONSULTANTS’s Fee. In consideration of the services to be rendered under this Agreement, the Company shall pay the CONSULTANT
1,250,000 shares of the Company’s common stock (the “Shares” or “TAUG shares”), fully vested upon
the execution of this agreement (January 8, 2019). The Shares shall be “restricted securities” as defined under Rule
144 of the Securities Act of 1933, as amended. Has potential to earn additional compensation, solely based on performance and
contributions to the Company (to be evaluated on an event to event basis).

 

(b)
CASH UP FRONT. $2,000 cash within 3 business days of execution date of this Consulting Agreement.

 

(c)
Expenses. The Company shall reimburse Consultant for all reasonable business expenses incurred in the performance of his duties
hereunder in accordance with Company’s expense reimbursement guidelines.

 

(d)
Indemnification. Company will indemnify and defend Consultant against any liability incurred in the performance of the Services
to the fullest extent authorized in Company’s Certificate of Incorporation, as amended, bylaws, amended, and applicable
law.

 

4.
Termination

 

(a)
Right to Terminate. At any time, Consultant may be terminated by the Company. Consultant may resign at any time. Notwithstanding
anything to the contrary contained in or arising from this Agreement or any statements, policies, or practices of Company, neither
Consultant nor Company shall be required to provide any advance notice or any reason or cause for termination of Consultant’s
status.

 

(b)
Automatic Termination. This Agreement shall terminate automatically upon the occurrence of any of the following events: (i)
the death of the Consultant; (ii) upon thirty days’ written notice from the Company in the event of the
Consultant’s Disability (as used herein, “Disability” means (A) the physical or mental disability which
prevents the Consultant from performing his obligations under this Agreement in substantially the same manner as performed
immediately before the applicable event for a period of three consecutive months or an aggregate of 90 days during any period
of 365 consecutive days) or (B) a written determination by a licensed medical doctor selected by the Company and reasonably
acceptable to the Consultant that the Consultant has incurred a physical or mental disability from which he will not be able
to recover sufficiently to return to full-time active employment hereunder within 180 days of the determination (a
“Permanent Disability”). The Consultant shall cooperate with and permit examination by any licensed medical
doctor retained by the Company to evaluate whether he has suffered a Permanent Disability (but in no event shall Consultant
be required to submit to any invasive or painful procedures); and (iii) bankruptcy or insolvency of the Consultant

 

    	 	 	 

     

    

 

(c)
Effect of Termination as Consultant. Upon a termination of Consultant’s status as a Consultant, this Agreement will terminate;
Company shall pay to Consultant all compensation and benefits to which Consultant is entitled up through the date of termination.
Thereafter, all of Company’s obligations under this Agreement shall cease, except as set forth in Section 5(c) hereof.

 

5.
Termination Obligations.

 

(a)
Consultant agrees that all property, including, without limitation, all equipment, tangible proprietary information, documents,
records, notes, contracts, and computer-generated materials provided to or prepared by Consultant incident to his services belong
to Company and shall be promptly returned at the request of Company.

 

(b)
Upon termination of this Agreement, Consultant shall be deemed to have resigned from all offices then held. Consultant agrees
that following any termination of this Agreement, he shall cooperate with Company in the winding up or transferring to other Consultants
of any pending work and shall also cooperate with Company (to the extent allowed by law, and at Company’s expense) in the
defense of any action brought by any third party against Company that relates to the Services.

 

(c)
The Company and Consultant agree that their obligations under this Section, as well as Sections 5, 6 and 7 shall survive the termination
of this Agreement.

 

6.
Nondisclosure Obligations.

 

Consultant
shall maintain in confidence and shall not, directly or indirectly, disclose or use, either during or after the term of this Agreement,
any Proprietor, Information (as defined below), confidential information, or trade secrets belonging to Company, whether or not
it is in written or permanent form, except to the extent necessary to perform the Services, as required by a lawful government
order or subpoena, or as authorized in writing by Company. These nondisclosure obligations also apply to Proprietary Information
belonging to customers and suppliers of Company, and other third parties, learned by Consultant as a result of performing the
Services. “Proprietary Information” means all information pertaining in any manner to the business of Company, unless
(i) the information is or becomes publicly known through lawful means; (ii) the information was part of Consultant’s general
knowledge prior to his relationship with Company; or (iii) the information is disclosed to Consultant without restriction by a
third party who rightfully possesses the information and did not learn of it from Company.

 

    	 	 	 

     

    

 

7.
Dispute Resolution.

 

Governing
Law; Arbitration. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New
York without giving effect to its principles of conflicts of law. Any dispute or controversy between the Company and Consultant,
arising out of or relating to this Agreement, the breach of this Agreement, or otherwise, shall be settled by binding arbitration
in New York, NY administered by the American Arbitration Association in accordance with its Rules then in effect by a single arbitrator.
The arbitration requirement applies to all statutory, contractual, and/or common law claims arising from the employment relationship
including, but not limited to, claims arising under Title VII of the Civil Rights Act of 1964; the Age Discrimination in
Employment Act; the Equal Pay act of 1963; the Fair Labor Standards Act, the American With Disabilities Act, and other applicable
federal and state employment laws. Both the Company and Consultant shall be precluded from bringing or raising in court or another
forum any dispute that was or could have been submitted to binding arbitration. This arbitration requirement does not apply to
claims for workers’ compensation benefits, claims arising under ERISA, or claims for any provisional or injunctive relief
remedies. The parties irrevocably agree to submit to the jurisdiction of the federal and state courts within Florida for any injunctive
relief and in connection with any suit arising out of the confirmation or enforcement of any award rendered by the arbitrator,
and waive any defense based on forum non-convenes or improper venue with respect thereto. [This conflicts with the earlier portion
of this paragraph, which says NY.] Each party shall pay their own attorney’s fees and costs. The arbitrator shall, within
thirty (30) days after the conclusion of the arbitration, issue a written award setting forth the factual and legal bases for
his or her decision and judgment upon the award rendered by the arbitrator may be entered in any court having jurisdiction thereof.
No remedy conferred in this Agreement upon the Consultant or the Company is intended to be exclusive of’ any other remedy,
and each and every such remedy shall be cumulative and shall be in addition to every other remedy conferred herein or now or hereafter
existing at law or in equity or by statute or otherwise.

 

NOTE:
THIS ARBITRAITION CLAUSE CONSTITUTES A WAIVER OF CONSULTANT AND OR CONSULTANT’S RIGHT TO A JURY TRIAL AND RELATES TO THE
RESOLUTION OF ALL DISPUTES RELATING TO ALL ASPECTS OF THE EMPLOYER/CONSULTANT RELATIONSHIP.

 

8.
Entire Agreement. This Agreement is intended to be the final, complete, and exclusive statement of the terms of
Consultant’s relationship solely with respect to his position as a consultant. This Agreement entirely supersedes and
may not be contradicted by evidence of any prior or contemporaneous statements or agreements pertaining to Consultant’s
relationship as an Consultant. Agreements related to Consultant’s ownership of the Securities are not affected by this
Agreement.

 

9.
Amendments; Waivers. This Agreement may not be amended except by a writing signed by Consultant and by a duly authorized representative
of the Company. Failure to exercise any right under this Agreement shall not constitute a waiver of such right.

 

10.
Assignment. Consultant agrees that Consultant will not assign any rights or obligations under this Agreement, with the exception
of Consultant’s ability to assign rights with respect to the Securities. Nothing in this Agreement shall prevent the consolidation,
merger or sale of Company or a sale of all or substantially all of its assets.

 

11.
Severability. If a court or arbitrator to be invalid, unenforceable, or void shall hold any provision of this Agreement, such
provision shall be enforced to fullest extent permitted by law, and the remainder of this Agreement shall remain in full force
and effect. In the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction
to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall
reduce the time period or scope to the maximum time period or scope permitted by law.

 

    	 	 	 

     

    

 

12.
Interpretation. This Agreement shall be construed as a whole, according to its fair meaning, and not in favor of or against any
party. Captions are used for reference purposes only and should be ignored in the interpretation of the Agreement.

 

13.
Binding Agreement. Each party represents and warrants to the other that the person(s) signing this Agreement below has authority
to bind the party to this Agreement and that this Agreement will legally bind both Company and Consultant. This Agreement will
be binding upon and benefit the parties and their heirs, administrators, executors, successors and permitted assigns. To the extent
that the practices, policies, or procedures of Company, now or in the future, are inconsistent with the terms of this Agreement,
the provisions of this Agreement shall control. Any subsequent change in Consultant’s duties or compensation will not affect
the validity or scope of the remainder of this Agreement.

 

14.
Consultant Acknowledgment. Consultant acknowledges Consultant has had the opportunity to consult legal counsel concerning this
Agreement, that Consultant has read and understands the Agreement, that Consultant is fully aware of its legal effect, and that
Consultant has entered into it freely based on his own judgment and not on any representations or promises other than those contained
in this Agreement.

 

15.
Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all
of which together shall constitute one and the same instrument.

 

16.
Date of Agreement. The parties have duly executed this Agreement as of the date first written above.

 

IN
WITNESSETH WHEREOF, the undersigned have executed this Agreement as of the date first above written.

 

[insert company name

 

	 	By:	 
	 	 	CONSULTANT
	 	 	J.
    Safier Enterprises LLC (C/o Jamie Safier)
	 	 	Jamie
    Safier (on behalf of LLC)
	 	 	 
	 	 	X
	 	 	Seth
    M. Shaw, Tauriga Sciences Inc.
	 	 	January
    11, 2019SECURITIES
PURCHASE AGREEMENT

 

Tauriga
Sciences Inc. (OTCQB: TAUG)

 

555
Madison Avenue, 5th Floor

 

New
York, NY 10022

 

Attn:
Seth M. Shaw, Chief Executive Officer. DATE: January 8, 2019

 

THIS
SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of January 8, 2019, by and among Tauriga Sciences,
Inc., a Florida corporation (the “Company”), and the Subscriber identified on the signature pages hereto (the
“Subscriber”).

 

WHEREAS,
the Company and the Subscriber are executing and delivering this Agreement in reliance upon an exemption from securities registration
afforded by the provisions of Section 4(2), Section 4(6) and/or Regulation D (“Regulation D”) as promulgated
by the United States Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933,
as amended (the “1933 Act”).

 

WHEREAS,
the parties desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to the
Subscriber, as provided herein, and the Subscriber shall purchase 1,000,000 shares (the “Purchased Shares”)
of the Company’s common stock, $.00001 par value (the “Common Stock”) at a per shares price of $0.02
for an aggregate purchase price of $20,000 (the “Purchase Price”).

 

NOW,
THEREFORE, in consideration of the mutual covenants and other agreements contained in this Agreement, the Company and the
Subscriber hereby agree as follows:

 

1.
Closing. On the Closing Date (as defined below), the Subscriber shall purchase and the Company shall sell to the Subscriber
the Purchased Shares. The Closing Date shall be the date the Subscriber funds the Purchase Price by wire transfer to the benefit
of the Company pursuant to the instructions set forth on Exhibit A hereto (the “Closing Date”).

 

2.
Subscriber’s Representations and Warranties. The Subscriber hereby represents and warrants to and agrees with the
Company as to such Subscriber that:

 

(a)
Information on Company. The Subscriber has received in writing from the Company such public information concerning its
operations, financial condition and other matters as the Subscriber has requested in writing, and considered all factors the Subscriber
deems material in deciding on the advisability of investing in the Securities.

 

    	 

    	 

    

 

(b)
Information on Subscriber. The Subscriber is as of the date hereof an “accredited investor”, as such term is
defined in Regulation D promulgated by the Commission under the 1933 Act, is experienced in investments and business matters,
has made investments of a speculative nature and has purchased securities of United States publicly-owned companies in private
placements in the past and, with its representatives, has such knowledge and experience in financial, tax and other business matters
as to enable the Subscriber to utilize the information made available by the Company to evaluate the merits and risks of, and
to make an informed investment decision with respect to, the proposed purchase. The Subscriber acknowledges that an investment
in the Securities represents a speculative investment. The Subscriber has the authority and is duly and legally qualified to purchase
and own the Securities. The Subscriber is able to bear the risk of such investment for an indefinite period and to afford a complete
loss of the investment. The information set forth on the signature page hereto regarding the Subscriber is true and correct.

 

(c)
Compliance with Securities Act. The Subscriber understands and agrees that the Securities have not been registered under
the 1933 Act or any applicable state securities laws, and are being issued in a transaction that does not require registration
under the 1933 Act (based in part on the accuracy of the representations and warranties of Subscriber contained herein), and that
such Securities must be held indefinitely unless the Securities are subsequently registered for resale under the 1933 Act or any
applicable state securities laws or is exempt from such registration.

 

(d)
Shares Legend. Upon issuance, the Purchased Shares shall bear the following or similar legend:

 

“THE
SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR ANY STATE SECURITIES LAW. NO TRANSFER OF THE SHARES REPRESENTED BY THIS CERTIFICATE SHALL BE VALID OR EFFECTIVE
UNLESS SUCH TRANSFER IS MADE (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND IN COMPLIANCE WITH
ANY APPLICABLE STATE SECURITIES LAWS, OR (B) PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND ANY APPLICABLE STATE OR LOCAL SECURITIES LAW (INCLUDING WITHOUT LIMITATION THE DELIVERY OF A LEGAL OPINION FROM COUNSEL TO
THE TRANSFEROR, REASONABLY SATISFACTORY, IF REQUESTED BY THE COMPANY).”

 

(e)
Communication of Offer. The offer to sell the Securities was directly communicated to the Subscriber by the Company. At
no time was the Subscriber presented with or solicited by any leaflet, newspaper or magazine article, radio or television advertisement,
or any other form of general advertising or solicited or invited to attend a promotional meeting otherwise than in connection
and concurrently with such communicated offer.

 

    	-2-

    	 

    

 

(f)
Authority; Enforceability. This Agreement and the other agreements delivered in connection with this Agreement have been
duly authorized, executed and delivered by the Subscriber and are valid and binding agreements enforceable in accordance with
their terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability
relating to or affecting creditors’ rights generally and to general principles of equity, Subscriber has full corporate
power and authority necessary to enter into this Agreement and such other agreements and to perform its obligations hereunder
and under all other agreements entered into by the Subscriber relating hereto.

 

(g)
Correctness of Representations. The Subscriber represents as to such Subscriber that the foregoing representations and
warranties are true and correct as of the date hereof and will be true and correct as of the Closing Date. The foregoing representations
and warranties shall survive the Closing Date for a period of three years.

 

(h)
Survival. The foregoing representations and warranties of the Subscriber shall survive the Closing Date for a period of
two years.

 

3.
Company Representations and Warranties. The Company represents and warrants to and agrees with the Subscriber that, except
as set forth in the Reports:

 

(a)
Due Incorporation. The Company and each of its subsidiaries is a corporation duly organized, validly existing and in good
standing under the laws of the respective jurisdictions of their incorporation and have the requisite corporate power to own their
properties and to carry on their business as now being conducted. The Company and each of its subsidiaries is duly qualified as
a foreign corporation to do business and is in good standing in each jurisdiction where the nature of the business conducted or
property owned by it makes such qualification necessary, other than those jurisdictions in which the failure to so qualify would
not have a material adverse effect on the business, operations or financial condition of the Company.

 

(b)
Outstanding Stock. All issued and outstanding shares of capital stock of the Company and each of its subsidiaries has been
duly authorized and validly issued and are fully paid and non-assessable.

 

(c)
Authority; Enforceability. This Agreement and any other agreements delivered in connection herewith (collectively “Transaction
Documents”) have been duly authorized, executed and delivered by the Company and are valid and binding agreements enforceable
in accordance with their terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and
similar laws of general applicability relating to or affecting creditors’ rights generally and to general principles of
equity. The Company has full corporate power and authority necessary to enter into and deliver the Transaction Documents and to
perform its obligations thereunder.

 

(d)
The Securities. The Securities upon issuance:

 

(i)
are, or will be, free and clear of any security interests, liens, claims or other encumbrances, subject to restrictions upon transfer
under the 1933 Act and any applicable state securities laws; and

 

    	-3-

    	 

    

 

(ii)
have been, or will be, duly and validly authorized and as of the Closing Date, the Securities will be duly and validly issued,
fully paid and nonassessable (and if registered pursuant to the 1933 Act, and if resold pursuant to an effective registration
statement will be free trading and unrestricted, provided that the Subscriber complies with the prospectus delivery requirements
of the 1933 Act);

 

(e)
Reporting Company. The Company is a publicly-held company subject to reporting obligations pursuant to Sections 15(d) and
13 of the Securities Exchange Act of 1934, as amended (the “1934 Act”) and has a class of common stock registered
pursuant to Section 12(g) of the 1934 Act. The Company is Current and is a fully reporting U.S. based public Company which has
its securities listed on the OTCQB Tier of OTC Markets.

 

(f)
No Market Manipulation. The Company has not taken, and will not take, directly or indirectly, any action designed to, or
that might reasonably be expected to, cause or result in stabilization or manipulation of the price of the Common Stock to facilitate
the sale or resale of the Securities or affect the price at which the Securities may be issued or resold.

 

(g)
Stop Transfer. The Securities, when issued, will be “restricted” securities, as that term is defined under
Rule 144 of the 1933 Act. The Company will not issue any stop transfer order or other order impeding the sale, resale or delivery
of any of the Securities, except as may be required by any applicable federal or state securities laws and unless contemporaneous
notice of such instruction is given to the Subscriber.

 

(h)
No Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has
directly or indirectly made any offers or sales of any security or solicited any offers to buy any security under circumstances
that would cause the offer of the Securities pursuant to this Agreement to be integrated with prior offerings by the Company for
purposes of the 1933 Act or any applicable stockholder approval provisions, including, without limitation, under the rules and
regulations of the Bulletin Board. The Company or any of its affiliates or subsidiaries will not take any action or steps that
would cause the offer of the Securities to be integrated with other offerings. The Company will not conduct any offering other
than the transactions contemplated hereby that will be integrated with the offer or issuance of the Securities.

 

(i)
No General Solicitation. Neither the Company, nor any of its affiliates, nor to its knowledge, any person acting on its
or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under
the 1933 Act) in connection with the offer or sale of the Securities.

 

(j)
Dilution. The Company’s executive officers and directors have studied and fully understand the nature of the Securities
being sold hereby and recognize that they have a potential dilutive effect on the equity holdings of other holders of the Company’s
equity or rights to receive equity of the Company. The board of directors of the Company has concluded, in its good faith business
judgment, that such issuance is in the best interests of the Company.

 

(k)
Going Concern: There can be no guaranty that the Company will be successful in its business initiatives and there is the possibility
that the Company will not be in business at some point in the future.

 

    	-4-

    	 

    

 

(l)
Survival. The foregoing representations and warranties shall survive the Closing Date for a period of six months.

 

4.
Regulation D Offering. The offer and issuance of the Securities to the Subscriber is being made pursuant to the exemption
from the registration provisions of the 1933 Act afforded by Section 4(2) or Section 4(6) of the 1933 Act and/or Rule 506 of Regulation
D promulgated thereunder. .

 

5.
Covenants of the Company and Subscriber Regarding Indemnification.

 

(a)
The Company agrees to indemnify, hold harmless, reimburse and defend the Subscriber, the Subscriber’ officers, directors,
agents, affiliates, control persons, and principal shareholders, against any claim, cost, expense, liability, obligation, loss
or damage (including reasonable legal fees) of any nature, incurred by or imposed upon the Subscriber or any such person which
results, arises out of or is based upon (i) any material misrepresentation by Company or breach of any warranty by Company in
this Agreement or in any Exhibits or Schedules attached hereto, or other agreement delivered pursuant hereto; or (ii) after any
applicable notice and/or cure periods, any breach or default in performance by the Company of any covenant or undertaking to be
performed by the Company hereunder, or any other agreement entered into by the Company and Subscriber relating hereto.

 

(b)
The Subscriber agrees to indemnify, hold harmless, reimburse and defend the Company and each of the Company’s officers,
directors, agents, affiliates, control persons against any claim, cost, expense, liability, obligation, loss or damage (including
reasonable legal fees) of any nature, incurred by or imposed upon the Company or any such person which results, arises out of
or is based upon (i) any material misrepresentation by such Subscriber in this Agreement or in any Exhibits or Schedules attached
hereto, or other agreement delivered pursuant hereto; or (ii) after any applicable notice and/or cure periods, any breach or default
in performance by such Subscriber of any covenant or undertaking to be performed by such Subscriber hereunder, or any other agreement
entered into by the Company and Subscribers relating hereto.

 

(c)
In no event shall the liability of any Subscriber or permitted successor hereunder or under any other agreement delivered in connection
herewith be greater in amount than the dollar amount of the net proceeds received by such Subscriber upon the sale of Registrable
Securities (as defined herein) giving rise to such indemnification obligation.

 

6.
Miscellaneous.

 

(a)
Notices. All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder
shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered
or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid,
or (iv) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party
shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder
shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting
facsimile machine, at the address or number designated below (if delivered on a business day during normal business hours where
such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during
normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by
express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first
occur. The addresses for such communications shall be: (i) if to the Company, to: Tauriga Sciences, Inc., 39 Old Ridgebury Road,
Danbury Connecticut 06180, and (ii) if to the Subscriber, to the address and telecopier number indicated on the signature page
hereto.

 

    	-5-

    	 

    

 

(b)
Closing. The consummation of the transactions contemplated herein (“Closing”) shall take place at the
offices of the Company or via email upon the satisfaction of all conditions to Closing set forth in this Agreement.

 

(c)
Entire Agreement; Assignment. This Agreement and other documents delivered in connection herewith represent the entire
agreement between the parties hereto with respect to the subject matter hereof and may be amended only by a writing executed by
both parties. Neither the Company nor the Subscriber have relied on any representations not contained or referred to in this Agreement
and the documents delivered herewith. No right or obligation of either party shall be assigned by that party without prior notice
to and the written consent of the other party.

 

(d)
Counterparts. This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed
to be an original and, all of which taken together shall constitute one and the same Agreement. In the event that any signature
is delivered by facsimile transmission, such signature shall create a valid binding obligation of the party executing (or on whose
behalf such signature is executed) the same with the same force and effect as if such facsimile signature were the original thereof.

 

(e)
Law Governing this Agreement. This Agreement shall be governed by and construed in accordance with the laws of the State
of New York without regard to principles of conflicts of laws. Any action brought by either party against the other concerning
the transactions contemplated by this Agreement shall be brought only in the state courts of New York or in the federal courts
located in the state of New York. The parties and the individuals executing this Agreement and other agreements referred to herein
or delivered in connection herewith on behalf of the Company agree to submit to the jurisdiction of such courts and waive trial
by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney’s fees and costs.
In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable
under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict
therewith and shall be deemed modified to conform to such statute or rule of law. Any such provision which may prove invalid or
unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.

 

(f)
Specific Enforcement, Consent to Jurisdiction. The Company and Subscriber acknowledge and agree that irreparable damage
would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms
or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent
or cure breaches of the provisions of this Agreement and to enforce specifically the terms and provisions hereof or thereof, this
being in addition to any other remedy to which any of them may be entitled by law or equity. Each of the Company and Subscriber
hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is not personally subject to
the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the
suit, action or proceeding is improper. Nothing in this Section shall affect or limit any right to serve process in any other
manner permitted by law.

 

[SIGNATURE
PAGE FOLLOWS]

 

    	-6-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}]]